6 天前 - … significantly higher risk of all-cause mortality compared with lower BMI categories.
… impact of body weight on efficacy and safety of DOACs and warfarin, the results …

46 天前 - … direct oral anticoagulants (DOACs) as first-line agents in patients with non-valvular
atrial fibrillation … the use of Apixaban in underweight patients, with some results suggesting …

100 天前 - … Abstract: Background: Direct oral anticoagulants (DOACs) are recommended for
stroke prevention in non-valvular atrial fibrillation (NVAF) patients. We aimed to describe the …

118 天前 - … due to the need of dose adjustment of non-vitamin K antagonist oral anticoagulants.
… patients. In ETNA-AF-Europe, patients with WRF were older, had lower body weights, were …

137 天前 - … elderly (≥80 years) patients with nonvalvular atrial fibrillation (NVAF) at high bleeding
… in patients with nonvalvular AF (NVAF) recommend the use of direct oral anticoagulants (…

181 天前 - … for treating patients at extremes of body weight in venous … cardioembolic stroke in
nonvalvular atrial fibrillation (NVAF)… Effect of body weight on efficacy and safety of direct oral …

241 天前 - … elderly (≥80 years) patients with nonvalvular atrial fibrillation (NVAF) at high bleeding
risk … (CES) patients with NVAF at high bleeding risk and direct oral anticoagulant (DOAC) …

285 天前 - … direct oral anticoagulants (DOACs) contained a limited representation of subjects
with abnormal body weight, which were mostly limited to a BMI … non-valvular atrial fibrillation in …

337 天前 - … Direct oral anticoagulants (DOACs) have emerged as appealing therapeutic
alternatives that provide providers and patients with more safe and convenient treatment options in …

341 天前 - … population direct oral anticoagulants (DOACs) have become the preferred treatment
for secondary VTE prevention and thrombosis prophylaxis in nonvalvular atrial fibrillation (…